Clinical Trial Update: CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS [Phase 3]

View source ↗

Summary

Phase 3 trial CANDIS-II is evaluating a cognitive-behavioral treatment program for cannabis use disorders; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Snippet

Sponsor: Technische Universität Dresden | Conditions: Cannabis Use Disorders | Phase 3 | Status: UNKNOWN